| Cell line name |
HB-CLS-2 |
|---|
| Synonyms |
HBCLS2 |
|---|
| Accession |
CVCL_6214 |
|---|
| Resource Identification Initiative |
To cite this cell line use: HB-CLS-2 (RRID:CVCL_6214) |
|---|
| Comments |
Part of: MD Anderson Cell Lines Project.
Population: Caucasian.
Omics: Proteomics; Expression; Reverse-phase protein array.
Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. |
|---|
| HLA typing |
Source: CLS=300191
| Class I | | HLA-A | A*24:02:01,32:01:01 | | HLA-B | B*27:02:00,55:01:01 | | HLA-C | C*02:02:02,03:03:01 | | Class II | | HLA-DP | DPB1*02:01,03:01 | | HLA-DQ | DQA1*01:05:01,04:01:01 | | DQB1*04:02:01,05:01:01 | | HLA-DR | DRB1*08:01:01,10:01:01 |
|
|---|
| Disease |
Bladder carcinoma (NCIt: C4912) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
50Y |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): CLS=300191
Markers:| Amelogenin | X,Y |
| CSF1PO | 7,10 |
| D3S1358 | 16 |
| D5S818 | 10,12 |
| D7S820 | 8,9 |
| D8S1179 | 13 |
| D13S317 | 11,12 |
| D16S539 | 12 |
| D18S51 | 15,17 |
| D21S11 | 32.2,35.2 |
| FGA | 21,23 |
| Penta D | 11,13 |
| Penta E | 13 |
| TH01 | 8,10 |
| TPOX | 11 |
| vWA | 15,18 |
Run an STR similarity search on this cell line |
|---|
| Web pages |
Info; MCLP; -; https://tcpaportal.org/mclp/ |
|---|
| Publications | PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Jun Li, Wei Zhao, Rehan Akbani, Wen-Bin Liu, Zhen-Lin Ju, Shi-Yun Ling, Christopher P. Vellano, Paul Roebuck, Qing-Hua Yu, A. Karina Eterovic, Lauren Averett Byers ...Show all 25 authors... , Michael A. Davies, Wan-Leng Deng, Y.N. Vashisht Gopal, Guo Chen, Erika Maria von Euw, Dennis Joseph Slamon, Dylan Conklin, John Victor Heymach, Adi F. Gazdar, John D. Minna, Jeffrey N. Myers, Yi-Ling Lu, Gordon B. Mills, Han Liang; Show fewer authors
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017) PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Tahlita C.M. Zuiverloon, Florus C. de Jong, James C. Costello, Dan Theodorescu;
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018) |
|---|
| Cross-references |
|---|
| Cell line collections (Providers) |
CLS; 300191
|
|---|
| Encyclopedic resources |
Wikidata; Q54881348
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 10-Apr-2025 |
|---|
| Version number | 17 |
|---|
